BlackRock, Inc. 13D and 13G filings for Artiva Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-23 8:14 pm Purchase |
2025-03-31 | 13G | Artiva Biotherapeutics, Inc. ARTV |
BlackRock Inc. BLK |
1,245,511 5.100% |
1,245,511 (New Position) |
Filing |